GLRX5 and chronic myelogenous leukemia, BCR-ABL1 positive: Therefore, combined with the results shown in Fig. 5B, CCDC26/miR-140-5p/GLRX5 and LINC01515/miR-425-5p/DICER1 may be potential ceRNA regulatory networks in drug resistance of CML.